VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

rMVTT- HPV16-E6/E7
Vaccine Information
  • Vaccine Name: rMVTT- HPV16-E6/E7
  • Target Pathogen: Cancer
  • Target Disease: Cancer
  • Vaccine Ontology ID: VO_0004761
  • Type: Recombinant vector vaccine
  • Status: Research
  • Host Species for Licensed Use: Baboon
  • E6 gene engineering:
    • Type: Recombinant protein preparation
    • Description: (Zhi et al., 2002)
    • Detailed Gene Information: Click Here.
  • E7 gene engineering:
    • Type: Recombinant protein preparation
    • Description:
    • Detailed Gene Information: Click Here.
  • Vector:
  • Preparation: (Zhi et al., 2002) In this vaccine, the HPV16 early E6 and E7 genes were expressing by a vaccinia virus TianTan vector.
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Mouse Response

  • Host Strain: C57 BL/6
  • Vaccination Protocol: Mice were vaccinated with VmE6E7 (Zhi et al., 2002).
  • Vaccine Immune Response Type: VO_0003057
  • Challenge Protocol: Mice were challenged by syngeneic HPV16E6 and E7 transformed tumor cells (Zhi et al., 2002).
  • Efficacy: The mice vaccinated expressed retarded or prevented tumor development (Zhi et al., 2002).
References
Zhi et al., 2002: Zhi H, Han L, Ren J, Tian H, Luo W, Liang Y, Ruan L. [Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology. 2002; 16(4); 341-344. [PubMed: 12665900].